[A16-77] Trifluridine/tipiracil (colorectal cancer) - Addendum to Commission A16-54
Last updated 02.02.2017
Commission awarded on 22.12.2016 by the Federal Joint Committee (G-BA).
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.
|A19-85||Trifluridine/tipiracil (gastric cancer) - Benefit assessment according to §35a Social Code Book V||Commission completed|
|A16-54||Trifluridine/tipiracil (colorectal cancer) - Benefit assessment according to §35a Social Code Book V||Commission completed|